Detalhe da pesquisa
1.
Neuropeptide regulation of non-redundant ILC2 responses at barrier surfaces.
Nature
; 611(7937): 787-793, 2022 11.
Artigo
Inglês
| MEDLINE | ID: mdl-36323781
2.
A combination of two human monoclonal antibodies limits fetal damage by Zika virus in macaques.
Proc Natl Acad Sci U S A
; 117(14): 7981-7989, 2020 04 07.
Artigo
Inglês
| MEDLINE | ID: mdl-32209664
3.
Development of a novel and efficient cell culture flocculation process using a stimulus responsive polymer to streamline antibody purification processes.
Biotechnol Bioeng
; 110(11): 2928-37, 2013 Nov.
Artigo
Inglês
| MEDLINE | ID: mdl-23740533
4.
A TCR mimic monoclonal antibody reactive with the "public" phospho-neoantigen pIRS2/HLA-A*02:01 complex.
JCI Insight
; 7(5)2022 03 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35260532
5.
Expression of the mono-ADP-ribosyltransferase ART1 by tumor cells mediates immune resistance in non-small cell lung cancer.
Sci Transl Med
; 14(636): eabe8195, 2022 03 16.
Artigo
Inglês
| MEDLINE | ID: mdl-35294260
6.
Therapeutic implications of a human neutralizing antibody to the macrophage-stimulating protein receptor tyrosine kinase (RON), a c-MET family member.
Cancer Res
; 66(18): 9162-70, 2006 Sep 15.
Artigo
Inglês
| MEDLINE | ID: mdl-16982759
7.
Single variable domain antibody as a versatile building block for the construction of IgG-like bispecific antibodies.
J Immunol Methods
; 318(1-2): 65-74, 2007 Jan 10.
Artigo
Inglês
| MEDLINE | ID: mdl-17126853
8.
Anti-vascular endothelial growth factor receptor-1 antagonist antibody as a therapeutic agent for cancer.
Clin Cancer Res
; 12(21): 6573-84, 2006 Nov 01.
Artigo
Inglês
| MEDLINE | ID: mdl-17085673
9.
Generation and characterization of a therapeutic human antibody to melanoma antigen TYRP1.
Hum Antibodies
; 16(3-4): 127-36, 2007.
Artigo
Inglês
| MEDLINE | ID: mdl-18334748
10.
Inhibitory anti-FLT3 antibodies are capable of mediating antibody-dependent cell-mediated cytotoxicity and reducing engraftment of acute myelogenous leukemia blasts in nonobese diabetic/severe combined immunodeficient mice.
Cancer Res
; 65(4): 1514-22, 2005 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-15735040
11.
Targeting the platelet-derived growth factor receptor alpha with a neutralizing human monoclonal antibody inhibits the growth of tumor xenografts: implications as a potential therapeutic target.
Mol Cancer Ther
; 4(3): 369-79, 2005 Mar.
Artigo
Inglês
| MEDLINE | ID: mdl-15767546
12.
A bi-functional antibody-receptor domain fusion protein simultaneously targeting IGF-IR and VEGF for degradation.
MAbs
; 7(5): 931-45, 2015.
Artigo
Inglês
| MEDLINE | ID: mdl-26073904
13.
Di-diabody: a novel tetravalent bispecific antibody molecule by design.
J Immunol Methods
; 279(1-2): 219-32, 2003 Aug.
Artigo
Inglês
| MEDLINE | ID: mdl-12969563
14.
A human monoclonal antibody targeting the stem cell factor receptor (c-Kit) blocks tumor cell signaling and inhibits tumor growth.
Cancer Biol Ther
; 15(9): 1208-18, 2014 Sep.
Artigo
Inglês
| MEDLINE | ID: mdl-24921944
15.
Removal of a C-terminal serine residue proximal to the inter-chain disulfide bond of a human IgG1 lambda light chain mediates enhanced antibody stability and antibody dependent cell-mediated cytotoxicity.
MAbs
; 5(3): 418-31, 2013.
Artigo
Inglês
| MEDLINE | ID: mdl-23567210
16.
The structural basis for the function of two anti-VEGF receptor 2 antibodies.
Structure
; 19(8): 1097-107, 2011 Aug 10.
Artigo
Inglês
| MEDLINE | ID: mdl-21827946
17.
IgG isotype, glycosylation, and EGFR expression determine the induction of antibody-dependent cellular cytotoxicity in vitro by cetuximab.
Hum Antibodies
; 19(4): 89-99, 2010.
Artigo
Inglês
| MEDLINE | ID: mdl-21178280
18.
Anti-transforming growth factor beta receptor II antibody has therapeutic efficacy against primary tumor growth and metastasis through multieffects on cancer, stroma, and immune cells.
Clin Cancer Res
; 16(4): 1191-205, 2010 Feb 15.
Artigo
Inglês
| MEDLINE | ID: mdl-20145179
19.
Development of a fully human anti-PDGFRbeta antibody that suppresses growth of human tumor xenografts and enhances antitumor activity of an anti-VEGFR2 antibody.
Neoplasia
; 11(6): 594-604, 2009 Jun.
Artigo
Inglês
| MEDLINE | ID: mdl-19484148
20.
An antibody directed against PDGF receptor beta enhances the antitumor and the anti-angiogenic activities of an anti-VEGF receptor 2 antibody.
Biochem Biophys Res Commun
; 357(4): 1142-7, 2007 Jun 15.
Artigo
Inglês
| MEDLINE | ID: mdl-17462601